ClicBio is revolutionizing the treatment of metabolic diseases by targeting the hunger pathway with a groundbreaking mechanism that acts as a pivotal molecular switch, regulating appetite through the modulation of hypothalamic neurons
ClicBio is revolutionizing the treatment of metabolic diseases by targeting the hunger pathway with a groundbreaking mechanism that acts as a pivotal molecular switch, regulating appetite through the modulation of hypothalamic neurons. In preclinical obesity models, inhibiting CLIC1 has been shown to induce weight loss comparable to GLP-1 agonists, while operating through an independent and additive pathway. Research further highlights the additional benefits of CLIC1 inhibition beyond appetite,